NCT04020926

Brief Summary

In this study patients with hyponatremia, defined as a serum sodium \< 126 mmol/L on admission to the hospital will be tested for muscular power by use of a hand grip dynamometer, for cognitive function by use of the Montreal-Cognitive-Assessment and gait stability by use of the Tinetti test. The tests will be performed on admission as well es after correction of hyponatremia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

June 25, 2020

Status Verified

June 1, 2020

Enrollment Period

6 months

First QC Date

July 10, 2019

Last Update Submit

June 23, 2020

Conditions

Keywords

hyponatremia

Outcome Measures

Primary Outcomes (3)

  • Muscle strength

    A.) Change in muscle strength in kilogram before and after correction of hyponatremia.

    Correction of hyponatremia (up to 1 week).

  • Mobility assessment

    B.) Change in results for the Tinetti performance-oriented mobility assessment (POMA) to evaluate static and dynamic balance abilities during and after correction of hyponatremia.

    Correction of hyponatremia (up to 1 week).

  • Cognitive Function

    C.) Change in results for the Montreal Cognitive Assessment (MOCA) test to assess mild cognitive impairment before and after correction of hyponatremia.

    Correction of hyponatremia (up to 1 week).

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We will include all consecutive patients \>/= 18 years with a serum sodium level \< 126 mmol/L on admission to the Hospital who give consent.

You may qualify if:

  • age 18 years or above
  • serum sodium ≤ 125 mmol/L
  • informed consent.

You may not qualify if:

  • age \< 18 years
  • not give or are not able to give informed consent
  • K+\<3.5 mmol/l
  • K+\>5.0 mmol/l)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Buergerspital Solothurn

Solothurn, Canton of Solothurn, 4500, Switzerland

Location

MeSH Terms

Conditions

Hyponatremia

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Gregor Lindner, M.D.

    Dept. of Internal and Emergency Medicine, Buergerspital Solothurn, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Dept. of Internal and Emergency Medicine

Study Record Dates

First Submitted

July 10, 2019

First Posted

July 16, 2019

Study Start

October 1, 2019

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

June 25, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations